FRIDAY, Nov. 8, 2024 (HealthDay News) -- The genetic testing rate is lower for Black than non-Hispanic White patients with ...

and colleagues in JAMA Ophthalmology. AI imaging was used 58.0 times per 100,000 patients in 2021, which slightly increased ...

Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...

Curcuma-based nutritional supplements (CBNS) have been scientifically established to possess antioxidant and ...

Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...

A shorter regimen of three cycles of adjuvant chemotherapy was noninferior to a standard six-cycle regimen among patients ...

The study, conducted in 2022, highlights significant variations in glaucoma prevalence across different demographic groups, ...

In a retrospective case series study, "Sterile Intraocular Inflammation Associated With Faricimab," published in JAMA Ophthalmology, researchers reviewed the records of seven patients referred to ...

New data support a change in management of the common eye disease glaucoma from eye drops, the current standard of care, to a ...

Genetic testing of patients with inherited retinal diseases may be less likely to turn up a conclusive diagnosis for certain racial groups, according to new research.

Only a small proportion of patients with diabetes have undergone artificial intelligence (AI)–based screening for diabetic ...